Clinical Trial Update: An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease

View source ↗

Summary

An observational study evaluating the use of lecanemab for early Alzheimer’s disease is currently recruiting, according to a ClinicalTrials.gov update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LEQEMBI (lecanemab)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Alzheimer Disease | Status: RECRUITING